Loading…

Direct selection of binding proficient/catalytic deficient variants of BamHI endonuclease

Variants of BamHI endonuclease in which the glutamate 113 residue has been changed to lysine or the aspartate 94 to asparagine were shown to behave as repressor molecules in vivo. This was demonstrated by placing a BamHI recognition sequence, GGATCC, positioned as an operator sequence in an antlsens...

Full description

Saved in:
Bibliographic Details
Published in:Nucleic acids research 1994-03, Vol.22 (6), p.1068-1074
Main Authors: Dorner, Lydia F., Schildkraut, Ira
Format: Article
Language:English
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page 1074
container_issue 6
container_start_page 1068
container_title Nucleic acids research
container_volume 22
creator Dorner, Lydia F.
Schildkraut, Ira
description Variants of BamHI endonuclease in which the glutamate 113 residue has been changed to lysine or the aspartate 94 to asparagine were shown to behave as repressor molecules in vivo. This was demonstrated by placing a BamHI recognition sequence, GGATCC, positioned as an operator sequence in an antlsense promoter for the aadA gene (spectinomycin resistance). Repression of this promoter relieved the inhibition of expression of spectinomycin resistance. This system was then used to select new binding proficient/cleavage deficient BamHI variants. The BamHI endonuclease gene was mutagenized either by exposure to hydroxylamine or by PCR. The mutagenized DNA was reintroduced into E.coil carrying the aadA gene construct, and trartsformants that conferred spectinomycin resistance were selected. Twenty Spr transformants were sequenced. Thirteen of these were newly isolated variants of the previously identified D94 and E113 residues which are known to be involved in catalysis. The remaining seven variants were all located at residue 111 and the glutamate 111 residue was shown to be involved with catalysis.
doi_str_mv 10.1093/nar/22.6.1068
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_307931</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>16807907</sourcerecordid><originalsourceid>FETCH-LOGICAL-i389t-57c850135867dbf7917eb3286ca54af33b76b8eb5d2138d6558aeae3a233fbb23</originalsourceid><addsrcrecordid>eNqFkL1vFDEQxS1EFI6EkhJpC0S3OXtn_VVQkITkIoWQAiSgscZebzDseS_2XkT--zjK6gQV1Wjm_d7ozRDymtEjRjUsI6Zl0xyJ0gn1jCwYiKZutWiekwUFymtGW_WCvMz5F6WsZbzdJ_tSUyVBL8j305C8m6rsh1LCGKuxr2yIXYg31SaNfXDBx2npcMLhfgqu6vw8q-4wBYxTfrQc43p1UfnYjXHrBo_ZH5K9HofsX831gHw9-_jlZFVffj6_OPlwWQdQeqq5dIpTBlwJ2dleaia9hUYJh7zFHsBKYZW3vGsYqE5wrtCjB2wAemsbOCDvn_ZutnbtO1eSJRzMJoU1pnszYjD_KjH8NDfjnQEqNbDifzf703i79Xky65CdHwaMftxmwzRwLiX8HxSqbKSygG_-TrSLMj-96G9nHbPDoU8YXcg7DLQsl_KC1U9YyJP_s5Mx_TZCguRm9e2H-XS9Oju-OgVzBQ92dKGn</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>16807907</pqid></control><display><type>article</type><title>Direct selection of binding proficient/catalytic deficient variants of BamHI endonuclease</title><source>PubMed Central (Open Access)</source><source>Oxford University Press Archive</source><creator>Dorner, Lydia F. ; Schildkraut, Ira</creator><creatorcontrib>Dorner, Lydia F. ; Schildkraut, Ira</creatorcontrib><description>Variants of BamHI endonuclease in which the glutamate 113 residue has been changed to lysine or the aspartate 94 to asparagine were shown to behave as repressor molecules in vivo. This was demonstrated by placing a BamHI recognition sequence, GGATCC, positioned as an operator sequence in an antlsense promoter for the aadA gene (spectinomycin resistance). Repression of this promoter relieved the inhibition of expression of spectinomycin resistance. This system was then used to select new binding proficient/cleavage deficient BamHI variants. The BamHI endonuclease gene was mutagenized either by exposure to hydroxylamine or by PCR. The mutagenized DNA was reintroduced into E.coil carrying the aadA gene construct, and trartsformants that conferred spectinomycin resistance were selected. Twenty Spr transformants were sequenced. Thirteen of these were newly isolated variants of the previously identified D94 and E113 residues which are known to be involved in catalysis. The remaining seven variants were all located at residue 111 and the glutamate 111 residue was shown to be involved with catalysis.</description><identifier>ISSN: 0305-1048</identifier><identifier>EISSN: 1362-4962</identifier><identifier>DOI: 10.1093/nar/22.6.1068</identifier><identifier>PMID: 7908739</identifier><identifier>CODEN: NARHAD</identifier><language>eng</language><publisher>Oxford: Oxford University Press</publisher><subject>Analytical, structural and metabolic biochemistry ; Aspartic Acid ; Base Sequence ; Binding Sites ; Biological and medical sciences ; Catalysis ; Deoxyribonuclease BamHI - chemistry ; Deoxyribonuclease BamHI - genetics ; Deoxyribonuclease BamHI - metabolism ; DNA - drug effects ; Drug Resistance ; Enzymes and enzyme inhibitors ; Escherichia coli ; Fundamental and applied biological sciences. Psychology ; Glutamates ; Glutamic Acid ; Hydrolases ; Hydroxylamine ; Hydroxylamines - pharmacology ; Molecular Sequence Data ; Mutagenesis ; Plasmids ; Polymerase Chain Reaction ; Promoter Regions, Genetic ; Repressor Proteins ; Sequence Analysis ; Spectinomycin - pharmacology</subject><ispartof>Nucleic acids research, 1994-03, Vol.22 (6), p.1068-1074</ispartof><rights>1994 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC307931/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC307931/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=3971385$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/7908739$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Dorner, Lydia F.</creatorcontrib><creatorcontrib>Schildkraut, Ira</creatorcontrib><title>Direct selection of binding proficient/catalytic deficient variants of BamHI endonuclease</title><title>Nucleic acids research</title><addtitle>Nucleic Acids Res</addtitle><description>Variants of BamHI endonuclease in which the glutamate 113 residue has been changed to lysine or the aspartate 94 to asparagine were shown to behave as repressor molecules in vivo. This was demonstrated by placing a BamHI recognition sequence, GGATCC, positioned as an operator sequence in an antlsense promoter for the aadA gene (spectinomycin resistance). Repression of this promoter relieved the inhibition of expression of spectinomycin resistance. This system was then used to select new binding proficient/cleavage deficient BamHI variants. The BamHI endonuclease gene was mutagenized either by exposure to hydroxylamine or by PCR. The mutagenized DNA was reintroduced into E.coil carrying the aadA gene construct, and trartsformants that conferred spectinomycin resistance were selected. Twenty Spr transformants were sequenced. Thirteen of these were newly isolated variants of the previously identified D94 and E113 residues which are known to be involved in catalysis. The remaining seven variants were all located at residue 111 and the glutamate 111 residue was shown to be involved with catalysis.</description><subject>Analytical, structural and metabolic biochemistry</subject><subject>Aspartic Acid</subject><subject>Base Sequence</subject><subject>Binding Sites</subject><subject>Biological and medical sciences</subject><subject>Catalysis</subject><subject>Deoxyribonuclease BamHI - chemistry</subject><subject>Deoxyribonuclease BamHI - genetics</subject><subject>Deoxyribonuclease BamHI - metabolism</subject><subject>DNA - drug effects</subject><subject>Drug Resistance</subject><subject>Enzymes and enzyme inhibitors</subject><subject>Escherichia coli</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Glutamates</subject><subject>Glutamic Acid</subject><subject>Hydrolases</subject><subject>Hydroxylamine</subject><subject>Hydroxylamines - pharmacology</subject><subject>Molecular Sequence Data</subject><subject>Mutagenesis</subject><subject>Plasmids</subject><subject>Polymerase Chain Reaction</subject><subject>Promoter Regions, Genetic</subject><subject>Repressor Proteins</subject><subject>Sequence Analysis</subject><subject>Spectinomycin - pharmacology</subject><issn>0305-1048</issn><issn>1362-4962</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1994</creationdate><recordtype>article</recordtype><recordid>eNqFkL1vFDEQxS1EFI6EkhJpC0S3OXtn_VVQkITkIoWQAiSgscZebzDseS_2XkT--zjK6gQV1Wjm_d7ozRDymtEjRjUsI6Zl0xyJ0gn1jCwYiKZutWiekwUFymtGW_WCvMz5F6WsZbzdJ_tSUyVBL8j305C8m6rsh1LCGKuxr2yIXYg31SaNfXDBx2npcMLhfgqu6vw8q-4wBYxTfrQc43p1UfnYjXHrBo_ZH5K9HofsX831gHw9-_jlZFVffj6_OPlwWQdQeqq5dIpTBlwJ2dleaia9hUYJh7zFHsBKYZW3vGsYqE5wrtCjB2wAemsbOCDvn_ZutnbtO1eSJRzMJoU1pnszYjD_KjH8NDfjnQEqNbDifzf703i79Xky65CdHwaMftxmwzRwLiX8HxSqbKSygG_-TrSLMj-96G9nHbPDoU8YXcg7DLQsl_KC1U9YyJP_s5Mx_TZCguRm9e2H-XS9Oju-OgVzBQ92dKGn</recordid><startdate>19940325</startdate><enddate>19940325</enddate><creator>Dorner, Lydia F.</creator><creator>Schildkraut, Ira</creator><general>Oxford University Press</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7TM</scope><scope>5PM</scope></search><sort><creationdate>19940325</creationdate><title>Direct selection of binding proficient/catalytic deficient variants of BamHI endonuclease</title><author>Dorner, Lydia F. ; Schildkraut, Ira</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-i389t-57c850135867dbf7917eb3286ca54af33b76b8eb5d2138d6558aeae3a233fbb23</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1994</creationdate><topic>Analytical, structural and metabolic biochemistry</topic><topic>Aspartic Acid</topic><topic>Base Sequence</topic><topic>Binding Sites</topic><topic>Biological and medical sciences</topic><topic>Catalysis</topic><topic>Deoxyribonuclease BamHI - chemistry</topic><topic>Deoxyribonuclease BamHI - genetics</topic><topic>Deoxyribonuclease BamHI - metabolism</topic><topic>DNA - drug effects</topic><topic>Drug Resistance</topic><topic>Enzymes and enzyme inhibitors</topic><topic>Escherichia coli</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Glutamates</topic><topic>Glutamic Acid</topic><topic>Hydrolases</topic><topic>Hydroxylamine</topic><topic>Hydroxylamines - pharmacology</topic><topic>Molecular Sequence Data</topic><topic>Mutagenesis</topic><topic>Plasmids</topic><topic>Polymerase Chain Reaction</topic><topic>Promoter Regions, Genetic</topic><topic>Repressor Proteins</topic><topic>Sequence Analysis</topic><topic>Spectinomycin - pharmacology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Dorner, Lydia F.</creatorcontrib><creatorcontrib>Schildkraut, Ira</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>Nucleic Acids Abstracts</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Nucleic acids research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Dorner, Lydia F.</au><au>Schildkraut, Ira</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Direct selection of binding proficient/catalytic deficient variants of BamHI endonuclease</atitle><jtitle>Nucleic acids research</jtitle><addtitle>Nucleic Acids Res</addtitle><date>1994-03-25</date><risdate>1994</risdate><volume>22</volume><issue>6</issue><spage>1068</spage><epage>1074</epage><pages>1068-1074</pages><issn>0305-1048</issn><eissn>1362-4962</eissn><coden>NARHAD</coden><abstract>Variants of BamHI endonuclease in which the glutamate 113 residue has been changed to lysine or the aspartate 94 to asparagine were shown to behave as repressor molecules in vivo. This was demonstrated by placing a BamHI recognition sequence, GGATCC, positioned as an operator sequence in an antlsense promoter for the aadA gene (spectinomycin resistance). Repression of this promoter relieved the inhibition of expression of spectinomycin resistance. This system was then used to select new binding proficient/cleavage deficient BamHI variants. The BamHI endonuclease gene was mutagenized either by exposure to hydroxylamine or by PCR. The mutagenized DNA was reintroduced into E.coil carrying the aadA gene construct, and trartsformants that conferred spectinomycin resistance were selected. Twenty Spr transformants were sequenced. Thirteen of these were newly isolated variants of the previously identified D94 and E113 residues which are known to be involved in catalysis. The remaining seven variants were all located at residue 111 and the glutamate 111 residue was shown to be involved with catalysis.</abstract><cop>Oxford</cop><pub>Oxford University Press</pub><pmid>7908739</pmid><doi>10.1093/nar/22.6.1068</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0305-1048
ispartof Nucleic acids research, 1994-03, Vol.22 (6), p.1068-1074
issn 0305-1048
1362-4962
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_307931
source PubMed Central (Open Access); Oxford University Press Archive
subjects Analytical, structural and metabolic biochemistry
Aspartic Acid
Base Sequence
Binding Sites
Biological and medical sciences
Catalysis
Deoxyribonuclease BamHI - chemistry
Deoxyribonuclease BamHI - genetics
Deoxyribonuclease BamHI - metabolism
DNA - drug effects
Drug Resistance
Enzymes and enzyme inhibitors
Escherichia coli
Fundamental and applied biological sciences. Psychology
Glutamates
Glutamic Acid
Hydrolases
Hydroxylamine
Hydroxylamines - pharmacology
Molecular Sequence Data
Mutagenesis
Plasmids
Polymerase Chain Reaction
Promoter Regions, Genetic
Repressor Proteins
Sequence Analysis
Spectinomycin - pharmacology
title Direct selection of binding proficient/catalytic deficient variants of BamHI endonuclease
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T21%3A05%3A41IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Direct%20selection%20of%20binding%20proficient/catalytic%20deficient%20variants%20of%20BamHI%20endonuclease&rft.jtitle=Nucleic%20acids%20research&rft.au=Dorner,%20Lydia%20F.&rft.date=1994-03-25&rft.volume=22&rft.issue=6&rft.spage=1068&rft.epage=1074&rft.pages=1068-1074&rft.issn=0305-1048&rft.eissn=1362-4962&rft.coden=NARHAD&rft_id=info:doi/10.1093/nar/22.6.1068&rft_dat=%3Cproquest_pubme%3E16807907%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-i389t-57c850135867dbf7917eb3286ca54af33b76b8eb5d2138d6558aeae3a233fbb23%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=16807907&rft_id=info:pmid/7908739&rfr_iscdi=true